Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nat. Rev. Neurol. doi: /nrneurol

Published byBrooke Harris Modified over 6 years ago

Similar presentations

Presentation on theme: "Nat. Rev. Neurol. doi: /nrneurol"— Presentation transcript:

1 Nat. Rev. Neurol. doi:10.1038/nrneurol.2016.13
Figure 6 Neuronal uptake of an anti-tau single-chain antibody facilitated by scanning ultrasound Figure 6 | Neuronal uptake of an anti-tau single-chain antibody facilitated by scanning ultrasound. A Myc-tagged (green) anti-tau single-chain antibody (ScFv, 25 kDa) was injected retro-orbitally into wild-type mice. Uptake into neurons in the brain was greater in animals that underwent scanning ultrasound (right) than in animals that did not (sham control, left). DAPI was used to visualize nuclei (blue). Scale bar, 10 μm. Götz, J. et al. (2016) Ultrasound treatment of neurological diseases — current and emerging applications Nat. Rev. Neurol. doi: /nrneurol

Download ppt "Nat. Rev. Neurol. doi: /nrneurol"

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Date of download: 6/3/2016 Copyright © 2016 SPIE. All rights reserved. (a) Confocal microscope images of human adipose-derived stem cells (hASCs) labeled.

Date of download: 6/3/2016 Copyright © 2016 SPIE. All rights reserved. (a) Confocal microscope images of human adipose-derived stem cells (hASCs) labeled.
Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi:10/1038/nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Life expectancy at birth in all countries included

Figure 3 Life expectancy at birth in all countries included
Figure 1 Perivenous distribution of multiple sclerosis lesions

Figure 1 Perivenous distribution of multiple sclerosis lesions
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 The US Centers for Disease Control and

Figure 2 The US Centers for Disease Control and
Figure 4 Time course of the development of physiological changes

Figure 4 Time course of the development of physiological changes
Figure 2 ALSFRS-R changes (A) Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) slope after 6 months of treatment without (left)

Figure 2 ALSFRS-R changes (A) Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) slope after 6 months of treatment without (left)
Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Supplementary Figure 2 Secondary transplanted brain tumors from PASC1 express human GH. Immuno-fluorescence staining of brain sections from mice implanted.

Supplementary Figure 2 Secondary transplanted brain tumors from PASC1 express human GH. Immuno-fluorescence staining of brain sections from mice implanted.
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Proportion of patients for whom NEDA

Figure 3 Proportion of patients for whom NEDA
Figure 5 Number of AHSCT procedures for

Figure 5 Number of AHSCT procedures for
Figure 4 Neuromyelitis optica spectrum disorder brain lesions

Figure 4 Neuromyelitis optica spectrum disorder brain lesions
Figure 2 Use of a brain–computer interface in severe chronic stroke

Figure 2 Use of a brain–computer interface in severe chronic stroke
Figure 2 Co-stimulatory receptors as immunomodulatory targets

Figure 2 Co-stimulatory receptors as immunomodulatory targets

Similar presentations

Ads by Google